Schroder Investment Management Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.84M | Sell |
|
|||||
|
2025
Q1 | $16.2M | Buy |
|
|||||
|
2024
Q4 | $12.7M | Buy |
|
|||||
|
2024
Q3 | $11.7M | Buy |
|
|||||
|
2024
Q2 | $6.13M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $6.46M | Hold |
|
|||||
|
2022
Q4 | $7.35M | Buy |
|
|||||
|
2022
Q3 | $6M | Buy |
|
|||||
|
2022
Q2 | $4.76M | Buy |
|
|||||
|
2022
Q1 | $5.84M | Buy |
|
|||||
|
2021
Q4 | $4.97M | Buy |
|
|||||
|
2021
Q3 | $5.62M | Buy |
|
|||||
|
2021
Q2 | $3M | Buy |
|
|||||
|
2021
Q1 | $2.71M | Buy |
|
|||||
|
2020
Q4 | $3.16M | Sell |
|
|||||
|
2020
Q3 | $3.08M | Buy |
|
|||||
|
2020
Q2 | $2.62M | Buy |
|
|||||
|
2020
Q1 | $1.72M | Buy |
|
|||||
|
2019
Q4 | $2.02M | Hold |
|
|||||
|
2019
Q3 | $1.39M | Buy |
|